Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Altor BioScience receives NCI grant to support bladder cancer trial

Aug. 20, 2014

Preclinical data on novel anti-human CCR9 MAb for leukemia

Aug. 20, 2014

Seattle Genetics begins phase I study of SGN-CD70A

Aug. 14, 2014

TapImmune confirms new clinical trial of folate receptor alpha peptide antigens

Aug. 12, 2014

Genetic modification of T-cell epitopes in therapeutic toxins to minimize immunogenic reactions

Aug. 11, 2014

Sym-004 advances into two new trials

Aug. 8, 2014

Regen BioPharma advances development of dCellVax

Aug. 6, 2014

GSK and Genmab report interim data for phase III study of ofatumumab in relapsed CLL

Aug. 5, 2014

Researchers at Xencor divulge new heterodimeric proteins

Aug. 4, 2014

AstraZeneca and Kyowa Hakko Kirin form clinical immuno-oncology collaboration

July 31, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 30, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...